Upstream Bio, Inc. (UPB)

Upstream Bio, Inc. (UPB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $151M; returns 1 day -8.4%, 1 week -0.7%, 1 year -87.0%.

Upstream Bio, Inc. (UPB) is a clinical-stage biotechnology firm dedicated to the creation of innovative treatments for inflammatory ailments, with a specific focus on severe respiratory conditions.

Groups UPB belongs to

• Biotechnology
• Clinical Stage
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Healthcare
• Antibody Therapeutics
• Monoclonal Antibodies
• Chronic Inflammatory Diseases
• Infectious Diseases
• Biopharmaceutical
• Pharmaceuticals
• Autoimmune Diseases
• Chronic Obstructive Pulmonary Disease (COPD)
• Life Sciences

UPB financial model: income statement, cash flow and balance sheet